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We are pleased to announce the formation of an affili-
ation between BMC Complementary and Alternative
Medicine and Cochrane Complementary Medicine. This
relationship has been fostered with the aim of improving
the rigor and transparency of Systematic Reviews pub-
lished within the journal.
Systematic reviews are considered to be the least
biased method to identify, evaluate, and summarize the
evidence on the effectiveness of an intervention [1]. Sys-
tematic reviews both sum up the available research and
identify any outstanding gaps in the evidence, and this
overall assessment then contributes to evidence-based
health-care decisions made by patients, clinicians and
policy makers. This is true for complementary and alter-
native therapies as well as for pharmaceutical drugs and
other conventional therapies.
The number of published systematic reviews has in-
creased dramatically over the last twenty years [2]. BMC
Complementary and Alternative Medicine alone has
published dozens since the journal was first established.
To be of value, however, systematic reviews should be
rigorously conducted and reported: poorly conducted
and poorly reported systematic reviews may be harmful
rather than helpful to the enterprise of summarizing the
best evidence on interventions, and such reviews are a
waste of limited research resources [3].
Cochrane, a non-profit organization established on
the basis of an international collaboration of health
researchers and other contributors, has been at the
forefront of systematic review methodology and pro-
duction since the organization was founded in 1993
[4]. The Cochrane Complementary Medicine Field
(cam.cochrane.org) was established in 1996 to support
and promote Cochrane systematic reviews of comple-
mentary, alternative, and integrative interventions.
BMC Complementary and Alternative Medicine’s part-
nership with the Cochrane Complementary Medicine
Field aims to strengthen the editorial processes for
systematic reviews at BMC Complementary and Alter-
native Medicine, and ultimately to improve the
reporting and the quality of systematic reviews pub-
lished in the journal.
A systematic review is defined as “a review of the sci-
entific evidence which applies strategies that limit bias in
the assembly, critical appraisal, and synthesis of all rele-
vant studies on the specific topic” [5]. Pre-specification
of the research question and review methods are the
primary instruments for reducing bias [6], therefore
while quality of conduct and quality of reporting are not
identical concepts they are linked and transparency and
completeness in reporting review methods is critical [7].
The planning and conduct of the review should be
reported in such a way that anyone reading the report can
assess the strengths and weaknesses of the systematic re-
view methods [8]. Since being developed 10 years ago,
PRISMA (Preferred Reporting Items of Systematic reviews
and Meta-Analyses) has become the widely accepted
standard for reporting of systematic reviews [7, 9].
Beginning in April of this year BMC Complementary
and Alternative Medicine expects all authors submitting
manuscripts of systematic reviews to adhere to the fol-
lowing criteria:
 To present a clear research question (population,
intervention, comparator, outcome(s)) for the review,
and associated eligibility criteria, that includes study
design, for including studies in the review;
 To have searched at least one electronic database
and reported the search strategy for that database;
 To have assessed the included studies for quality or
risk of bias, and used the results of this assessment
to inform the conclusions of the review; and
 To complete the most recent PRISMA checklist
(www.prisma-statement.org) for the above elements
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as well as all other items on the checklist. Where
applicable authors will be required to follow and
submit extended PRISMA statements (see www.
prisma-statement.org/Extensions/)
Assessment against these criteria will form part of the
initial editorial process for all systematic reviews that are
submitted to the journal. Authors will now be required
to submit a PRISMA checklist upon submission of sys-
tematic reviews and meta-analyses to BMC Complemen-
tary and Alternative medicine. The completion of a
PRISMA checklist will aid authors in ensuring that their
manuscript meets the reporting requirements, and the
submission of a completed PRISMA checklist together
with the manuscript will speed the checking of the
manuscript, and progression to peer review.
To facilitate and maintain standards of systematic
reviews at the journal the Editorial Board for BMC Com-
plementary and Alternative Medicine is being expanded
with the creation of a new role, Systematic Review Edi-
tor. Systematic Review Editors are members of the
Cochrane Complementary Medicine Field and their sole
responsibility will be initial assessment of submitted sys-
tematic review manuscripts.
The intentions with this initiative are two-fold: to
establish clear criteria against which an initial assess-
ment of systematic reviews can be carried out and to
streamline and increase the efficiency of the journal’s
editorial process. We hope you will join us on our jour-
ney to ensure that systematic reviews in the complemen-
tary and alternative medicine field meet the highest
standards of conduct and reporting and that those that
do so are published expediently.
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